Collaboration with the Masaryk Memorial Cancer Institute
Our great collaboration with the Department of Nuclear Medicine and PET Center Masaryk Memorial Cancer Institute, Brno, as well as the Department of Neurosurgery, St. Anne’s University Hospital, Brno, Czech Republic, resulted in a manuscript where we compared sensitivity of 18F-FET and 18F-FLT in diagnosis of low grade gliomas.
Dear doc. Zdenek Rehak, thank you for this wonderful collaboration!
Link to the article: FET and FCH in low grade gliomas August 2021
New article published in Radiology and Oncology journal
We are proud to announce our new article “Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients” published in Radiology and Oncology journal: Final Hodolic_3783_RadiologyAndOncology
Thank you: Daniela Ehrlich, Andreas Dunzinger, Gertraud Malsiner-Walli, Bettina Grün, Raffi Topakian, Elmar Kainz and Robert Pichler for many years of fruitful collaboration!
New articles published in collaboration with Kepler University Linz!
IASON @ the European Congress of Nuclear Medicine 2021
IASON in VODICE, September 3-5, 2021
After 2 years of ‘Covid and no congresses’ time, Iason participated in the Croatian congress of Nuclear Medicine in Vodice, where Prof. Dr. Marina Hodolic gave a talk on radiolabeled neurotensin in malignancies with neurotensin receptors.
Here are some photos from Vodice:
“18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study” article
Ana Mišir Krpan, Anja Tea Golubić, Maja Baučić, Jakob Nemir, Goran Mrak, Marijan Žuvić, Dražen Huić from University Hospital Center in Zagreb, Croatia together with Marina published their work
18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study
in Croatian Medical Journal.
Thank you University Hospital Center Zagreb, Croatia for this long lasting friendship!
Marina Hodolic and our scientific collaborators from Linz, Austria published a new article: Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course
Iason would like to announce that great scientific team from Kepler University Hospital, Linz, Austria
Ognian Kalev, Berndt Tomancok, Michael Sonnberger, Markus Hutterer, Daniela Ehrlich, Robert Pichler
together with our Marina Hodolic published a new article
“Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course” in journal Endokrynologia Polska.
The first in human use of our new radiopharmaceutical 68Ga-NT-20.3 (IASOtensin®). Article published!
IASON is very proud to announce that the first in human use of our new radiopharmaceutical 68Ga-NT-20.3 has been performed!
Prof. Dr. Marina Hodolic presents the results in her article
“Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in human use”
The article was written together with our great collaborators from the Department of Nuclear Medicine, Nanjing First Hospital, Nanjing, China and was published in the famous European Journal of Nuclear Medicine.
A new manuscript on 18F-FET (IASOglio®) and 18F-DOPA (IASOdopa®) published in Frontiers in Neuroscience
Our scientific collaborators from Policlinico San Matteo, Pavia, Italy together with Marina realized and presented in the manuscript work
“Effects of photons’ irradiation on 18F-FET and 18F-DOPA uptake by T98G glioblastoma cells” Article published
PASI Francesca, PERSICO Marco Giovanni, MARENCO Manuela, VIGORITO Martina, FACOETTI Angelica, HODOLIC Marina, NANO Rosanna, CAVENAGHI Giorgio, LODOLA Lorenzo, APRILE Carlo!!!
IASON´s scientific presentations at EANM 2020
Our innovative scientific work was presented at the European Congress of Nuclear Medicine 2020, delivered as oral presentations:
VASINA, J., HODOLIC, M, JANCALEK, R., MACKERLE, Z., HENDRYCH, M., et al. 18F-FET of 18F-FLT PET/CT in diagnosis of low-grade gliomas? A pilot study.
BOSSERT, I., HODOLIC, M, CHYTIRIS, S, D’AMBROSIO, D., MARCHETTO, A., et al. Optimization of 18F-Fluorocholine PET/CT protocol in parathyroid imaging.
HODOLIC, M, GOLUBIC, A. T., MISIR KRPAN, A., ZUVIZ, M, BAUCIC BOZIC, M, MRAK, G, NEMIR, J, HUIC, D. Primary diagnosis of low-grade glioma: 18F-FET or 18F-FCH PET?
WANG, F, WU, W, VIRGOLINI, I, HODOLIC, M. The first in human use of 68Ga-NT-20.3: radiopharmaceutical for imaging of neurotensin receptors. Safety data.
We would also like to express our sincere gratitude to
University Hospital Brno, Czech Republic
Scientific Institute Maugeri, Pavia, Italy
University Hospital Centre, Zagreb, Croatia
Nanjing first Hospital, Nanjing, China
The EANM 2020 was a success for all of us!
European Medical Journal Oncology published IASON´s work in collaboration with the University Medical Centre Zagreb, Croatia
“18F-FET or 18F-FCH PET/CT in the primary diagnosis of low-grade glioma: a pilot study”
HODOLIC Marina, MISIR KRPAN Ana, GOLUBIC Anja, BAUCIC BOZIC Maja, NEMIR Jakob, MRAK Goran, ZUVIC Marijan and HUIC Drazen, continue the scientific collaboration between IASON and its valuable customers!
IASON @ the EANM 2020
IASON will be present at the EANM (European Association of Nuclear Medicine) Congress in Vienna, which will take place from October 17th to 21st 2020.
We are extremely proud to announce our scientific work there, made in collaboration with the Nanjing First Hospital, Nanjing, China, the University Hospital Centre Zagreb, Croatia, the University Hospital of Brno, Czech Republic, and the Istituti Clinici Scientifici Maugeri in Pavia, Italy.
IASON @ the European Congress of Radiology in Vienna, July 15th to 19th 2020
We are happy to tell you that IASON’s Marina Hodolic will present our work on PET diagnostics of low grade gliomas, made in collaboration with the University Hospital Center of Zagreb, Croatia, at this year’s European Congress of Radiology in Vienna.
You can watch Marina’s online presentation from July 15th following this link: https://connect.myesr.org/ecr-2020/
New Manuscript on Neurotensin: “Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer”
We are very happy to announce the publication of a new manuscript, written by Marina Hodolic, Valentina Ambrosini and Stefano Fanti, on the ‘Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer’ (see excerpt here). IASON is pleased that this article was announced as ‘Highlight article of the current issue’ of Nuclear Medicine Communication Journal (see here).
IASON @ Congress of Nuclear Medicine in Zell am See
We are happy to announce that IASON will be present at the
35th international Austrian Winter Symposium of Nuclear Medicine and Molecular Imaging in Zell am See, from January 22th-25th 2020.
We are honored to present our work on 18F-FET and 18 F-FCH in patients with low grade gliomas, made in collaboration with the University Hospital Center of Zagreb, Croatia.
See you in Zell am See! 🙂
Merry Christmas and a Happy New Year 2019
One more year is behind us and Christmas is just around the corner…
I would like to thank all of IASON’s scientific collaborators for the great work we did together!
I am looking forward to again making this world a better place for the patients, with the help of all of you, in the year 2019!
IASON talks at Nitra, Slovakia and Skopje, Macedonia
IASON’s Assoc.-Prof. Marina Hodolic will give a talk on the topic of
“The role of PET/CT in diagnosis and treatment of brain tumours”
The scientific meeting organized by the Macedonian Association of Nuclear Medicine will take place at the University Institute of Positron Emission Tomography of Skopje, Macedonia, on December 12th, 2019.
Marina also presented IASON’s work on 18F-FET – made in collaboration with the University Hospital Centre Zagreb, Croatia and the Masaryk University Brno, Czech Republic – at the
Nuclear medicine days in Nitra, Slovakia
which took place from November 27th to 29th, 2019.
New manuscript in “Current Pharmaceutical Biotechnology” published
IASON´s great collaboration with a group of scientists from Pavia, Italy, resulted in the manuscript
“Evidence of 68Ga-DOTA-NT-20.3 uptake in pancreatic adenocarcinoma AsPC-1 cell line – in vitro study”
published in the journal “Current Pharmaceutical Biotechnology”.
Please see the abstract here
New article published!
As a result of a successful collaboration between IASON and great group of scientists from Italy, an article has been published in the Journal of Endocrinological Investigation:
PET/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism
Please read the article here.
· Luca Chiovato, Unit of Internal Medicine and Endocrinology, ICS Maugeri and of University of Pavia, Italy
· Laura Croce, Unit of Internal Medicine and Endocrinology, ICS Maugeri and of University of Pavia, Italy
· Spyridon Chytiris, Unit of Internal Medicine and Endocrinology, ICS Maugeri, Pavia, Italy
· Luigi Mansi, Inter-Universitary Research Center for Sustainable Development (CIRPS), Napoli-Roma, Italy
· Giuliano Mariani, Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy
· Marina Hodolic. Nuclear Medicine Research Department, Iason, Graz, Austria and Nuclear Medicine Department, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic and Nuclear Medicine Department, Policlinico S. Orsola Malpighi, University of Bologna, Bologna, Italy
· Irene Bossert, Unit of Nuclear Medicine, ICS Maugeri, Pavia, Italy
· Giuseppe Trifirò, Unit of Nuclear Medicine, ICS Maugeri, Pavia, Italy
IASON study presented at European Congress of Neurosurgery in Dublin
We are happy to announce that our work “18F-FET and 18F-choline PET/CT in patients with newly diagnosed low-grade gliomas: a pilot study”, which was written in collaboration with a group from the University Hospital in Zagreb, Croatia, is going to be presented at the European congress of neurosurgery in Dublin in September 2019.
1st Neurooncology International Course in Dubrovnik, September 29 – October 1, 2019
We are proud to announce that our work “New radiopharmacs in low grade gliomas” made in collaboration with University Hospital Centre Zagreb, Croatia, will be presented on the 1st Neurooncology International Course in Dubrovnik.
Please see the program here:Program 1st Neurooncology International Course.
IASON at Czech Congress of Oncology 2019
IASON at Balkan Congress of Nuclear Medicine 2019
Assoc. Prof. Marina Hodolič will give a talk “18F-FET and 18F-choline PET/CT in patients with newly diagnosed low-grade gliomas: a pilot study“ at Balkan congress of nuclear medicine which will take a place in Turkey, Bodrum from April 10-14, 2019.
XIV Congresso Nazionale AIMN 2019
We are proud to announce that the following of our scientific works will be presented at the Italian Congress of Nuclear Medicine, which is taking place in Rimini (IT) from April 11th to14th 2019:
“The comparison of 18F-FET and 18F-choline in patients with newly diagnosed low-grade gliomas: a pilot study” Poster LGG Rimini 2019
“Targeting neurotensin receptor positive tumours: in vitro binding of pancreatic ductal adenocarcinoma with 68Ga-DOTA-neurotensin engineered fragment” Poster_PDAC_AIMN_2019
“Targeting neurotensin receptor positive tumours: in vitro binding of malignant pleural mesothelioma with 68Ga-DOTA-neurotensin engineered fragment” Poster-mesothelioma-AIMN_2019
“Effects of irradiation with photons and carbon ions on 18F-DOPA uptake by T98G glioblastoma cell line. Comparison with 18F-FET in vitro study” Poster AIMN 2019
“Prognostic value of [18F]ﬂuorocholine PET parameters in metastatic castrate–resistant prostate cancer treated with docetaxel”
New manuscript in “Contrast Media & Molecular Imaging” published
We are pleased to let you know that our article “Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel” has been published in “Contrast Media & Molecular Imaging”.
Please access our article at the following location:
Article accepted for European Congress of Radiology 2019 in Vienna
We are happy to inform you that our work, as a result of a fruitful collaboration with a scientific group from IRCCS ICS Maugeri, Pavia, Italy, the following work has been accepted for the European Congress of Radiology, which will take place in Vienna from February 27th to March 3rd 2019.
Prognostic value of [18F]Fluorocholine PET parameters in metastatic castrate–resistant prostate cancer treated with docetaxel
E. Quaquarini, D. D’ambrosio, F. Sottotetti, F. Gallivanone, M. Hodolic, C. Porta, R. Palumbo, A. Bernardo, G.Trifirò
IASON at EANM Congress in Dusseldorf, October 13-17, 2018
Scientific work with our customers:
“Can we image Malignant Pleural Mesothelioma with 68Ga-DOTA-Neurotensine analogue? In vitro study”
M. Marenco; M. G. Persico; G. Cavenaghi; V. Frangipane; F. Meloni; L. Lodola; M. Hodolič.
“PET/CT With 18F-fluorocholine May Detect Parathyroid Adenomas Also In Preclinical Or Subclinical Stage”
Bossert I; Mansi L; Hodolič M; Chytiris S; Croce L; Chiovato L; Mariani G; Trifirò G.
IASON at Czech Congress of Nuclear Medicine in Mikulov, September 19th-21st, 2018
Assoc. Prof. Marina Hodolič gave a talk on “18F-FET and 18F-FCH uptake on glioblastoma multiforme T98G cell line: in vitro study” at the Czech congress of nuclear medicine in Mikulov, which took place from September 19th to 21st.
Please see the program here: http://dnynm.cz/odborny-program-hlavni-kongresovy-sal
Please see a picture from the Congress here.
IASON would especially like to thank their business partner Lacomed spol s.r.o. for their support in this congress.
Presentation at Congress in Paris
We are pleased to inform you that our work “68Ga-DOTA-NT-20.3. An innovative probe for neurotensin receptor-positive tumor imaging in the diagnosis of malignant pleural mesothelioma” has been selected for oral presentation at the European Respiratory Society International Congress in Paris 2018, September 15th-19th 2018.
Authors: M. Marenco; V. Frangipane; M. Hodolic; S. Inghilleri; G.Stella; F. Meloni; L. Lodola
We are thankful to the Nuclear Medicine Department of the IRCCS Policlinico San Matteo Foundation and the Unit of Respiratory Diseases of the IRCCS Policlinico San Matteo Foundation in Pavia, Italy, for the fruitful collaboration!
Please see a picture of the presentation here.
IASON at the 50th Anniversary of the Nuclear Medicine Department in Osijek, Croatia
IASON was present at the 50th anniversary of the Nuclear Medicine department in Osijek, Croatia.
Assoc. Professor of Medicine, Marina Hodolič, M.D., Ph.D., IASON’s Clinical Research Supervisor, was invited to give a talk on the occasion of this big anniversary.
Please see the program here.
IASON at the 14th Panhellenic Congress of Nuclear Medicine
IASON at the 7th National Congress GICR in Ferrara (IT)
IASON will be present at the VII Congresso Nazionale GICR in Ferrara (IT) on May 11-12th with presentations of the following scientific work:
“Uptake di [18F]-FCH, [18F]-FET e [18F]F-DOPA in cellule di glioblastoma multiforme umano in condizioni basali e dopo irraggiamento con fotoni e ioni carbonio” from the authors Vigorito M.1, Pasi F.1,2*, Persico M.G.3,4, Marenco M.3, Facoetti A.5, Hodolic M.6, Nano R.1, Lodola L.3
“Neurotensin receptor imaging: 68Ga-DOTA-NT-20.3 uptake on pancreatic ductal adenocarcinoma cell line”, written by Marenco M.1*, Persico M.G.1,2, Hodolič M.3,4, Frangipane V.1, Cavenaghi G.1, Facoetti A.5, Aprile C.5, Lodola L.1
IASON scientific activities at the EANM 2017 in Vienna
IASON is pleased to announce that a great scientific collaboration with our customers resulted in several scientific activities at the EANM – Annual Congress of the European Association of Nuclear Medicine (October 21st to 25th 2017 in Vienna, Austria):
IASON scientific activities at the EANM 2017 Congress in Vienna
IASON is pleased to announce that a great scientific collaboration with our customers resulted in several scientific activites at the EANM – Annual Congress of the European Association of Nuclear Medicine, which took place from October 21st to 25th 2017 in Vienna, Austria:
Comparison between 18F-Choline (FCH) PET/CT and conventional imaging (CI) in intermediate-high risk prostate cancer (PCa) patients: design and preliminary data of a phase III Italian Multicenter Randomized Trial
IASON at the National Conference of Cytometry, Paestrum, Italy
IASON is present at the XXXV National Conference of Cytometry in Paestrum, Italy, from October 3rd to 6th 2017, with the following scientific work:
18F-FET,18F-FCH AND 18F-DOPA UPTAKE IN HUMAN GLIOBLASTOMA T98G CELLS
This is a result of a collaboration with:
– S.C. Medicina Nucleare, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
– Scuola Universitaria Superiore IUSS, Pavia, Italy
– S.C. Radioterapia Oncologica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
– Lab. Neuro-Radio Biologia Sperimentale, Dipartimento di Biologia e Biotecnologie “L.Spallanzani”, Università degli Studi di Pavia, Italy
– CNAO, Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
Persico M.G., Pasi F., Lodola L., Hodolič M., Facoetti A., Baio A., Aprile C., Nano R.
IASON talk at Fondazione Salvatore Maugeri Pavia, Italy
IASON Scientific Advisor Assoc.-Prof- Dr. Marina HODOLIC is going to give a talk about 18F-FET in patients with gliomas.
After the great interest in her talk at the CNAO in Pavia, she has been invited to give a talk at the Fondazione Salvatore Maugeri in Pavia, Italy.
When: October 12th 2017, at 11 am
Where: Fondazione Salvatore Maugeri Pavia, aula Capodaglio
IASON at the CNAO in Pavia
On September 18th 2017 at CNAO Pavia, IASON Scientific Advisor Assoc.-Prof- Dr. Marina HODOLIC presented “IASOglio in patients with gliomas”: the audience showed a great interest in this topic!
The National Centre of Oncological Hadrontherapy (CNAO) located in Pavia is the first Centre of Hadrontherapy in Italy which has been provided with a beam that is able to irradiate tumours with protons or carbon ions.
Hadrontherapy uses protons and atomic nuclei (ions) called hadrons (from the Greek hadrós, strong), which are subjected to a strong nuclear force, for treating radio-resistant or inoperable tumours. Nowadays the interest in hadrontherapy is growing rapidly. By 2020 it is expected that there will be almost 100 centres around the world, with over 30 of these being located in Europe.
IASON presentation at Congress in Rovinj (CRO)
On Saturday May 6th (6 p.m.) IASON’s Scientific Advisor Assoc.-Prof. Dr. Marina HODOLIC is going to give an oral presentation on 18F-FET AND 18F-FCH UPTAKE ON HUMAN GLIOBLASTOMA T98G CELLS: IN VITRO STUDY at the 9th International Congress of the Croatian Society of Nuclear Medicine (May 4th to 7th in Rovinj, Croatia), which is the result of a collaboration with the policlinico San Matteo (Pavia, Italy).
IASON at the 6th Balkan Congress of Nuclear Medicine in Sofia
New article published!
New article published in Clinical Nuclear Medicine
IASON lectures in 2016
In 2016, IASON Scientific Advisor Assoc.-Prof- Dr. Marina HODOLIC held lectures on 18F-PET/CT in patients with glioblastoma at the following venues:
– Banja Luka (BIH), 2nd February (hospital meeting)
– Zagreb (HR), 5th April (hospital meeting)
– Lecce (IT), 7th – 9th April, 25th Corso di aggiornamento nazionale AIMN in medicina nucleare (invited lecture)
– Pisa (IT), 31st May (hospital meeting)
– Modena (IT), July 13th (hospital meeting)
– Ospedale San Donatto, Arezzo, October 4th (hospital meeting)
– Instituto Neurologico Carlo Besta, Milano, November 17th (hospital meeting)
IASON at EANM Congress in Barcelona
As every year, IASON participated in the annual congress of the European Association of Nuclear Medicine (EANM), which took place from October 15th to 18th in Barcelona.
The congress was a great success and also featured scientific contributions from IASON (see links below).
Abstract on Sarcoidosis accepted at the CHEST 2016
IASON Scientific Advisor Assoc.-Prof- Dr. Marina HODOLIC is the co-author of an abstract which has been accepted at the CHEST 2016 Annual Meeting in Los Angeles!
The title of the abstract: Sarcoidosis – Follow up with 18F-FDG PET/CT after different therapy
The authors: Marjeta Terčelj1, Nadja Koren Pucelj1, Maša Bizjak1, Kaja Šifer1, Marina Hodolič2, Barbara Salobir1
1Klinični oddelek za pljučne bolezni in alergijo, Univerzitetni klinični center Ljubljana, Zaloška cesta 7, Medicinska fakulteta, Ljubljana, Slovenija
2Nuclear medicine research department Iason, Graz, Austria, Medical Faculty Olomouc, Czech Republic
New article: 18F – Fluorodeoxyglucose and 18F- Flumazenil Positron emission tomography in patients with refractory epilepsy
Article: 18F-FDG PET/CT in the initial assessment and for follow-up in patients with tuberculosis
IASON at the IAEA Conference in Vienna
IASON was present at last October’s IAEA conference in Vienna, where IASON Scientific Advisor Assoc.-Prof- Dr. Marina HODOLIC presented her paper on Malignant Incidental Findings on 18F-FDG PET/CT Scans in Patients with Tuberculosis.
Article: Hypoxia PET tracers in EBRT dose planning in head and neck cancer
IASON at EANM Conference in Hamburg
Article: Gleason score at diagnosis of 18F-CHOLINE PET/CT performed when biochemical evidence indicates recurrence of prostate cancer